Biograil

Private

RoskildeHealthcare & Life Scienceshttps://biograil.com/

Last Round

Series B

Jul 1, 2025

Total Funding Raised

$17.31M

Company Overview

Biograil is a therapeutic devices company that is developing a medical device designed to replace the standard injection system of medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

oral drug deliveryoral biologicsdrug delivery platforminjectable to oral conversionrobotic pillmicroneedle pillBIONDDSlarge molecule deliveryingestible deviceoral peptidesdrug delivery technologytechnology licensingBiologic Oral-delivery Non-invasive Device Systemgastric-adherent device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Biograil Comps

Public and private peers based on sector, stage, and business model.

Biograil comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Biograil Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Jul 1, 2025
Seed	Apr 5, 2024
Grant	Mar 14, 2022
Seed	Feb 17, 2022
Seed	Jan 15, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Karsten Lindhardt

Chief Executive Officer

Executive Team

Nikolaj Skak

Chief Technology Officer

Executive Team

Biograil Investors

Notable investors and investment history

Biograil investors
Investor	Rounds
Innovation Fund Denmark	Grant
Verve Ventures	Seed, Series B
Sanner Ventures	Seed
Roquette Ventures	Seed
Evonik Venture Capital	Seed
MEGATREND INVEST A/S	Seed, Series B
High-Tech Gründerfonds	Seed, Series B

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Mar 2, 2026
Monthly visitors grew 195% MoM, reaching 1.2K.
Jan 24, 2026
Monthly visitors increased 578% MoM, from 58 to 393.

View all signals

Biograil Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Biograil Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Biograil's valuation, stock price, and market status.

Firmographic Details

HeadquartersRoskilde

Employee Range31

Year Founded2019

Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.